Modulation of iron metabolism by iron chelation regulates intracellular calcium and increases sensitivity to doxorubicin

Bosnian Journal of Basic Medical Sciences
Leman Yalcintepe, Emre Halis

Abstract

Increased intracellular iron levels can both promote cell proliferation and death, as such; iron has a "two-sided effect" in the delicate balance of human health. Though the role of iron in the development of cancer remains unclear, investigations of iron chelators as anti-tumor agents have revealed promising results. Here, we investigated the influence of iron and desferrioxamine (DFO), the iron chelating agent on intracellular calcium in a human leukemia cell line, K562. Iron uptake is associated with increased reactive oxygen species (ROS) generation. Therefore, we showed that iron also caused dose-dependent ROS generation in K562 cells. The measurement of intracellular calcium was determined using Furo-2 with a fluorescence spectrophotometer. The iron delivery process to the cytoplasmic iron pool was examined by monitoring the fluorescence of cells loaded with calcein-acetoxymethyl. Our data showed that iron increased intracellular calcium, and this response was 8 times higher when cells were incubated with DFO. K562 cells with DFO caused a 3.5 times increase of intracellular calcium in the presence of doxorubicin (DOX). In conclusion, DFO induces intracellular calcium and increases their sensitivity to DOX, a chemotherapeu...Continue Reading

Citations

Jan 8, 2018·Annals of Hematology·Leilismara SousaLeandro Augusto Barbosa
Oct 13, 2020·Frontiers in Oncology·Eric GrignanoDidier Bouscary
Jul 1, 2021·World Journal of Clinical Oncology·Alejandro EspañolMaría Elena Sales
Nov 25, 2021·The Journal of Cell Biology·Anabella AguileraMaría Victoria Martin

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.